Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Ohya

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical Calcium|January 26, 2019
[The prevention and treatment of vascular calcification.]Kazuki Kawakami, Masaki Ohya, Takashi Shigematsu
Clinical and Experimental Nephrology|August 19, 2011
Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patientsMasaki Ohya, Haruhisa Otani, Keigo Kimura, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
A Survey of Drug Burden in Patients Undergoing Maintenance Hemodialysis in JapanYuko Iwashita, Masaki Ohya, Satoko Kunimoto, et al.
Internal Medicine (Tokyo, Japan)|October 9, 2010
Improved assessment of aortic calcification in Japanese patients undergoing maintenance hemodialysisMasaki Ohya, Haruhisa Otani, Keigo Kimura, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
An Analysis of Medication Adherence and Patient Preference in Long-term Stable Maintenance Hemodialysis Patients in JapanMasaki Ohya, Yuko Iwashita, Satoko Kunimoto, et al.
International Journal of Clinical Pharmacy|February 7, 2020
Correlation between haemoglobin level and type of erythropoiesis-stimulating agent at initiation of haemodialysisMasaki Higashiura, Masaki Ohya, Yusuke Tanaka, et al.
Clinical Nephrology|April 6, 2013
Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patientsMasaki Ohya, Haruhisa Otani, Yoshinobu Minami, et al.
Seminars in Dialysis|May 9, 2018
Acute kidney injury: Epidemiology, outcomes, complications, and therapeutic strategiesShigeo Negi, Daisuke Koreeda, Sou Kobayashi, et al.
Clinical and Experimental Nephrology|November 16, 2024
SGLT2 inhibitors increase low serum magnesium levels in patients with chronic kidney disease immediately after treatmentKosuke Osawa, Masaki Ohya, Shuto Yamamoto, et al.
American Journal of Physiology. Renal Physiology|August 27, 2010
Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTHFumie Saji, Takashi Shigematsu, Toshifumi Sakaguchi, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical Calcium|January 26, 2019
[The prevention and treatment of vascular calcification.]Kazuki Kawakami, Masaki Ohya, Takashi Shigematsu
Clinical and Experimental Nephrology|August 19, 2011
Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patientsMasaki Ohya, Haruhisa Otani, Keigo Kimura, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
A Survey of Drug Burden in Patients Undergoing Maintenance Hemodialysis in JapanYuko Iwashita, Masaki Ohya, Satoko Kunimoto, et al.
Internal Medicine (Tokyo, Japan)|October 9, 2010
Improved assessment of aortic calcification in Japanese patients undergoing maintenance hemodialysisMasaki Ohya, Haruhisa Otani, Keigo Kimura, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
An Analysis of Medication Adherence and Patient Preference in Long-term Stable Maintenance Hemodialysis Patients in JapanMasaki Ohya, Yuko Iwashita, Satoko Kunimoto, et al.
International Journal of Clinical Pharmacy|February 7, 2020
Correlation between haemoglobin level and type of erythropoiesis-stimulating agent at initiation of haemodialysisMasaki Higashiura, Masaki Ohya, Yusuke Tanaka, et al.
Clinical Nephrology|April 6, 2013
Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patientsMasaki Ohya, Haruhisa Otani, Yoshinobu Minami, et al.
Seminars in Dialysis|May 9, 2018
Acute kidney injury: Epidemiology, outcomes, complications, and therapeutic strategiesShigeo Negi, Daisuke Koreeda, Sou Kobayashi, et al.
Clinical and Experimental Nephrology|November 16, 2024
SGLT2 inhibitors increase low serum magnesium levels in patients with chronic kidney disease immediately after treatmentKosuke Osawa, Masaki Ohya, Shuto Yamamoto, et al.
American Journal of Physiology. Renal Physiology|August 27, 2010
Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTHFumie Saji, Takashi Shigematsu, Toshifumi Sakaguchi, et al.
Pageof 4